BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37213092)

  • 1. Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative Study.
    Crandall CJ; Larson JC; Schousboe JT; Manson JE; Watts NB; Robbins JA; Schnatz P; Nassir R; Shadyab AH; Johnson KC; Cauley JA; Ensrud KE
    JAMA Intern Med; 2023 Jul; 183(7):696-704. PubMed ID: 37213092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study.
    Crandall CJ; Larson J; LaCroix A; Cauley JA; LeBoff MS; Li W; LeBlanc ES; Edwards BJ; Manson JE; Ensrud K
    J Gen Intern Med; 2019 Feb; 34(2):235-242. PubMed ID: 30334182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report.
    Burnett-Bowie SM; Wright NC; Yu EW; Langsetmo L; Yearwood GMH; Crandall CJ; Leslie WD; Cauley JA
    J Bone Miner Res; 2024 Apr; ():. PubMed ID: 38590141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis screening in postmenopausal women 50 to 64 years old: comparison of US Preventive Services Task Force strategy and two traditional strategies in the Women's Health Initiative.
    Crandall CJ; Larson J; Gourlay ML; Donaldson MG; LaCroix A; Cauley JA; Wactawski-Wende J; Gass ML; Robbins JA; Watts NB; Ensrud KE
    J Bone Miner Res; 2014 Jul; 29(7):1661-6. PubMed ID: 24431262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture prediction from FRAX for Canadian ethnic groups: a registry-based cohort study.
    Leslie WD; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA
    Osteoporos Int; 2021 Jan; 32(1):113-122. PubMed ID: 32809043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of fracture risk prediction by the US Preventive Services Task Force strategy and two alternative strategies in women 50-64 years old in the Women's Health Initiative.
    Crandall CJ; Larson JC; Watts NB; Gourlay ML; Donaldson MG; LaCroix A; Cauley JA; Wactawski-Wende J; Gass ML; Robbins JA; Ensrud KE
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4514-22. PubMed ID: 25322268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four tools to identify painful new osteoporotic vertebral fractures in the postmenopausal population in Beijing.
    Guo S; An N; Lin J; Fan Z; Meng H; Yang Y; Fei Q
    Front Endocrinol (Lausanne); 2022; 13():1013755. PubMed ID: 36425464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital X-ray radiogrammetry in the study of osteoporotic fractures: Comparison to dual energy X-ray absorptiometry and FRAX.
    Kälvesten J; Lui LY; Brismar T; Cummings S
    Bone; 2016 May; 86():30-5. PubMed ID: 26921822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of women aged 50-64 yr for bone density measurement.
    Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    J Clin Densitom; 2013; 16(4):570-8. PubMed ID: 23452870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of screening tools for optimizing fracture prevention in Canada.
    Leslie WD; Lix LM; Binkley N
    Arch Osteoporos; 2020 Oct; 15(1):170. PubMed ID: 33111193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI).
    Harvey NC; Kanis JA; Liu E; Cooper C; Lorentzon M; Bea JW; Carbone L; Cespedes Feliciano EM; Laddu DR; Schnatz PF; Shadyab AH; Stefanick ML; Wactawski-Wende J; Crandall CJ; Johansson H; McCloskey E
    J Bone Miner Res; 2021 Apr; 36(4):654-661. PubMed ID: 33450071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Race/Ethnicity on United States FRAX Calculations and Treatment Qualification: A Registry-Based Study.
    Leslie WD;
    J Bone Miner Res; 2023 Dec; 38(12):1742-1748. PubMed ID: 37548387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Utility of Genetic Risk Score to Improve Performance of FRAX for Fracture Prediction in US Postmenopausal Women.
    Xiao X; Wu Q
    Calcif Tissue Int; 2021 Jun; 108(6):746-756. PubMed ID: 33560447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.
    Azagra R; Roca G; Encabo G; Aguyé A; Zwart M; Güell S; Puchol N; Gene E; Casado E; Sancho P; Solà S; Torán P; Iglesias M; Gisbert MC; López-Expósito F; Pujol-Salud J; Fernandez-Hermida Y; Puente A; Rosàs M; Bou V; Antón JJ; Lansdberg G; Martín-Sánchez JC; Díez-Pérez A; Prieto-Alhambra D
    BMC Musculoskelet Disord; 2012 Oct; 13():204. PubMed ID: 23088223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials.
    Crandall CJ; Larson J; Cauley JA; Schousboe JT; LaCroix AZ; Robbins JA; Watts NB; Ensrud KE
    JBMR Plus; 2019 Dec; 3(12):e10239. PubMed ID: 31844827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a genome-wide polygenic score in improving fracture risk assessment beyond the FRAX tool in the Women's Health Initiative study.
    Xiao X; Wu Q
    PLoS One; 2023; 18(6):e0286689. PubMed ID: 37262069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of fracture risk assessment in Asian and Black women.
    Lo JC; Chandra M; Yang W; Thompson N; Lee C; Ramaswamy M; Khan M; Wheeler A
    Am J Manag Care; 2024 Mar; 30(3):140-144. PubMed ID: 38457822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.